Serum Galectin-3 as a Marker of Human Papillomavirus Infection
Condition(s):Human Papillomavirus InfectionLast Updated:August 22, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Human Papillomavirus InfectionLast Updated:August 22, 2023Completed
Condition(s):Human Papilloma Virus InfectionLast Updated:May 10, 2023Recruiting
Condition(s):Cervical CancerLast Updated:September 5, 2016Unknown status
Condition(s):Human Papillomavirus Clearance at 12 MonthsLast Updated:August 10, 2010Terminated
Condition(s):Human Papillomavirus-Related Cervical CarcinomaLast Updated:April 26, 2023Active, not recruiting
Condition(s):Neoplasms, Uterine Cervix; Cervical CancerLast Updated:April 30, 2012Completed
Condition(s):Human Papilloma VirusLast Updated:February 21, 2020Completed
Condition(s):Infections, Papillomavirus; Cervical CancerLast Updated:November 22, 2012Completed
Condition(s):Human Papillomavirus InfectionLast Updated:October 6, 2020Completed
Condition(s):HPVLast Updated:August 25, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.